TG治疗公司
TGTX
53.97
-2.03
-3.63%
TG治疗公司
US · TGTX
#1638 按市值排名
上市于 1970
53.97
-2.03
-3.63%
实时 - 追踪5344个代码 - 心跳于205秒前
· 2026-10-16 19:33
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 83.26% +0.00pp
- 机构数量
- 497 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund58.53%
Hedge Fund14.72%
Public Company4.84%
Individual/Insider4.62%
Private Company2.82%
Government Pension Fund1.28%
Insurance Company0.83%
Family Office/Trust0.20%
Other12.13%
主要股东 截至 2026-06-30
BlackRock
15.54% · 22.05M 股
Vanguard Portfolio Management, LLC
5.61% · 7.96M 股
State Street Global Advisors
5.49% · 7.79M 股
Vanguard Capital Management, LLC
5.01% · 7.11M 股
Michael Weiss
3.46% · 4.90M 股
Opus Point Partners
3.44% · 4.87M 股
Geode Capital Management, LLC
2.57% · 3.64M 股
D. E. Shaw & Co., L.P.
2.40% · 3.40M 股
Soleus Capital Management, L.P.
2.06% · 2.93M 股
T. Rowe Price Group, Inc.
1.95% · 2.77M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪47份申报 · 21次买入 · 26次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michael Weiss | Chairperson & CEO | 3.46% |
| Sean Power | CFO, Corporate Secretary & Treasurer | 0.49% |
| Kenneth Hoberman | Independent Director | 0.20% |
| Yann Echelard | Independent Director | 0.16% |
| Daniel Hume | Independent Director | 0.14% |
| Laurence Charney | Lead Independent Director | 0.12% |
| Sagar Lonial | Independent Director | 0.07% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-09 | Laurence Charney | Lead Independent Director | Open Market Disposition | -5,000 | $54.96 |
| 2026-08-06 | Laurence Charney | Lead Independent Director | Other Disposition | -6,050 | -- |
| 2026-06-10 | Laurence Charney | Lead Independent Director | Other Derivative Acquisition | +8,325 | -- |
| 2026-06-10 | Kenneth Hoberman | Independent Director | Other Derivative Acquisition | +8,325 | -- |
| 2026-06-10 | Yann Echelard | Independent Director | Other Derivative Acquisition | +8,325 | -- |
| 2026-06-10 | Sagar Lonial | Independent Director | Other Derivative Acquisition | +8,325 | -- |
| 2026-06-10 | Daniel Hume | Independent Director | Other Derivative Acquisition | +8,325 | -- |
| 2026-01-28 | Laurence Charney | Lead Independent Director | Other Disposition | -43,197 | -- |
| 2026-01-07 | Michael Weiss | Chairperson & CEO | Other Acquisition | +622,000 | -- |
| 2026-01-07 | Sean Power | CFO, Corporate Secretary & Treasurer | Other Acquisition | +90,000 | -- |
| 2025-11-23 | Yann Echelard | Independent Director | Open Market Disposition | -5,000 | $32.57 |
| 2025-11-04 | Michael Weiss | Chairperson & CEO | Other Disposition | -4,668,843 | -- |
| 2025-09-10 | Sagar Lonial | Independent Director | Open Market Disposition | -20,852 | $32.24 |
| 2025-06-12 | Yann Echelard | Independent Director | Open Market Disposition | -10,000 | $36.94 |
| 2025-06-11 | Laurence Charney | Lead Independent Director | Other Acquisition | +21,408 | -- |
| 2025-06-11 | Kenneth Hoberman | Independent Director | Other Acquisition | +14,718 | -- |
| 2025-06-11 | Yann Echelard | Independent Director | Other Acquisition | +14,718 | -- |
| 2025-06-11 | Sagar Lonial | Independent Director | Other Acquisition | +14,718 | -- |
| 2025-06-11 | Daniel Hume | Independent Director | Other Acquisition | +14,718 | -- |
| 2025-03-16 | Daniel Hume | Independent Director | Other Disposition | -62,459 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:33:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
TG治疗公司 讨论区 0 条评论